Application of the adverse outcome pathway to identify molecular changes in prenatal brain programming induced by IUGR: Discoveries after EGCG exposure

Abstract

Following a multi-disciplinary approach integrating information from several experimental models we have collected new evidence supporting, expanding and redesigning the AOP 'Disrupted laminin/int-β1 interaction leading to decreased cognitive function'. Investigations in vitro in rabbit and rat neurospheres and in vivo in mice exposed to EGCG (epigallocatechin-gallate) during neurodevelopment are combined with in vitro evaluations in neural progenitor cells overexpressing int-β1 and literature information from int-β1 deficiency models. We have discovered for the first time that neural progenitor cells from intrauterine growth restricted (IUGR) animals overexpress int-β1 at gene and protein level and due to this change in prenatal brain programming they respond differently than control neurospheres to the exposure of EGCG, a compound triggering neural progenitor cell migration alterations. We have also identified that EGCG developmental exposure has deleterious effects on neuronal branching and arborization in vitro and in vivo. Our results warn that a thorough developmental neurotoxicity characterization of this and other catechin-based food supplements is needed before recommending their consumption during pregnancy

This study has been funded by Instituto de Salud Carlos III through the project “PI18/01763” (co-funded by European Regional Development Fund, "A way to make Europe"), from “LaCaixa” Foundation under grant agreements LCF/PR/GN14/10270005 and LCF/PR/GN18/10310003, and from AGAUR under grant 2017 SGR n° 1531. B.A.K. received a scholarship from Fundació Bosch i Gimpera (project number: 300155)